KT&G sees slight Q1 sales growth but profits decline

Apr.24.2023
KT&G sees slight Q1 sales growth but profits decline
KT&G's Q1 sales grew 0.1%, but operating profit dropped 17% due to higher input costs and a decline in real estate sales.

According to reports from Korean media, KT&G's comprehensive sales in the first quarter grew by 0.1% year-on-year to 14 trillion Korean Won ($1.05 billion), while operating profit fell by 17% to 2.761 trillion Korean Won ($207 million), which is expected to fall short of market expectations.


The reason for the decline in sales, according to Jang Ji-hye, a researcher at the Korean securities firm DS Investment & Securities, is that the cost of tobacco leaves has gone up, leading to a continued lack of profitability for cigarettes after the previous quarter. Additionally, there was a significant decrease in performance due to a decline in sales for the high-margin real estate business in Suwon.


Jang Ji-hye stated that due to the increased cost of cigarettes and a decline in the real estate industry, it is expected that KT&G's annual performance this year will struggle.


It is worth mentioning that Jang Ji-hye stated that KT&G's NGP business and KGC Ginseng Corporation had a stable performance in the first quarter. The decline was offset by strong sales of electronic cigarettes and new product Lil Able.


Jang Ji-hye stated that "although this year's performance is expected to be slightly subdued, KT&G is working with PMI to increase the number of NGP countries and showing a higher ratio of NGP compared to other global cigarette manufacturers.


He added: "Therefore, it is expected that the share of NGP business in KT&G's overall performance will increase from 14.7% in 2022 to 20.4% in 2027.


Further Reading:


Korean tobacco company, KT&G, has increased its short-term borrowing limit to 800 billion South Korean won. The company now requires a medium to long-term investment of 3.9 trillion South Korean won.


South Korea May Abandon Tax Hike on HNB, which Currently has a Tax Rate 90.4% Higher than Regular Cigarettes.


Phimo International's South Korean subsidiary appoints new CEO.


Reference(s):


KT&G, a South Korean tobacco company, has reported a steady growth in its electronic cigarette business and plans to expand its NGP (Next Generation Products) division within the group.


Effectiveness of switching to electronic cigarettes" - KT&G smiles


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
Apr.02 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
UK Bill Banning Tobacco Sales to People Born After 2008 Clears Parliament
UK Bill Banning Tobacco Sales to People Born After 2008 Clears Parliament
A UK bill banning the legal sale of tobacco to people born on or after January 1, 2009 has completed its passage through parliament. Under the bill, those born in that group will never be able to be legally sold tobacco anywhere in the UK. The legislation is expected to receive royal assent next week. It also gives ministers powers to strengthen public-place smoking restrictions and restricts branding, promotion and advertising of vape and nicotine products aimed at children.
Apr.22 by 2FIRSTS.ai
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s new tobacco and nicotine framework marks a shift from prohibition toward registration, traceability and health surveillance. Argentine THR advocate Juan Facundo Teme told 2Firsts that adult consumers and parts of the local commercial sector are cautiously optimistic, but concerns remain over flavor limits, registration costs and market access. The policy’s implementation may determine whether Argentina can move informal sales into regulated channels.
May.11
IVG Adds Six New Flavours to Pro Range, Expanding Line-Up to 39
IVG Adds Six New Flavours to Pro Range, Expanding Line-Up to 39
IVG has added six new flavours to its Pro range, taking the total line-up to 39 flavours. The new additions are Cola Frost, Rainbow Burst, Pineapple Tropic, Blueberry Raspberry, Strawberry Raspberry Ice and Raspberry Cherry Blueberry. All six are available only in 20mg nicotine strength, with an RRP of £10.95 for a starter kit and £7.95 for a refill pod.
Apr.21 by 2FIRSTS.ai